ATX-101(Abcon Therapeutics)

N/A

Report date: 2024/05/16 17:32:07

Base Information

Drug NameATX-101(Abcon Therapeutics)
Drug Alias NameATX-101(Abcon Therapeutics)ATX101(Abcon Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD6
TargetsT-cell differentiation antigen CD6
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbcon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbcon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLymphoma, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A